The Pharmacological Sciences Training Program provides training through the Pharmacology Track of the UCSD Biomedical Sciences (BMS) Graduate Program and seeks to provide trainees with a contemporary education in Pharmacology and state-of-the-art research training in Pharmacological Sciences. Didactic and experiential efforts prepare graduates for a wide range of career opportunities in academia and industry, where their broad scope of training in pharmacology, integrated with sister disciplines of physiology and molecular sciences, will be valued. Faculty interests and training areas emphasize understanding signaling pathways that are relevant to disease, elucidating new targets for drug action and using novel approaches to identify chemicals that modulate drug targets. The Training Faculty work in interdigitating areas, the largest of which is Signal Transduction. This category encompasses work on receptors and G-proteins, kinases and phosphatases, intracellular signaling pathways, cancer and growth regulation. Other major areas include Cardiovascular Science, Neuroscience, Drug Discovery and Protein Structure, Pharmacogenomics and Genetics, Drug Metabolism and Transport, and Endocrinology and Metabolism. Trainees take the Molecules to Organisms core course and Seminar course together with other BMS students in the Fall of year one. Subsequent courses given by the Pharmacology Track are required for all students in the Training Program (and encouraged for Trainees associated with the Program). Requirements are: Two quarters of the Drugs and Disease course, Seminars in Pharmacology, and three elective courses: one in a quantitative area, one an organ systems lab course and one dealing with pharmacokinetics or drug disposition. All Trainees participate in weekly Department of Pharmacology Research Discussions and host luncheons with seminar speakers. Two yearly Retreats provide Trainees with opportunities to interact with faculty and present their research progress. The Training Grant is in its 29th year and supports 15 trainees (approved for 16). Trainees are supported by the Training Grant for 2-3 years and obtain their Ph.D. in an average 5.6 years. We request an increase to 19 stipends based on continuously increasing faculty and graduate student growth at UCSD, the high quality of students we attract, and the opening and expansion of the Skaggs School of Pharmacy and Pharmaceutical Sciences Relevance: We train students in pharmacology so they will find better drugs to treat disease. Trainees learn basic science and do cutting edge research leading to an understanding of how the body works, what happens when diseases develop, how to intervene so that these changes might be prevented or blocked, and how to develop improved therapeutic agents to correct the dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007752-34
Application #
8286983
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Okita, Richard T
Project Start
1979-07-01
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
34
Fiscal Year
2012
Total Cost
$575,738
Indirect Cost
$31,838
Name
University of California San Diego
Department
Pharmacology
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Bajaj, Jeevisha; Konuma, Takaaki; Lytle, Nikki K et al. (2016) CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia. Cancer Cell 30:792-805
Fox, Raymond G; Lytle, Nikki K; Jaquish, Dawn V et al. (2016) Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. Nature 534:407-11
Nicklisch, Sascha C T; Rees, Steven D; McGrath, Aaron P et al. (2016) Global marine pollutants inhibit P-glycoprotein: Environmental levels, inhibitory effects, and cocrystal structure. Sci Adv 2:e1600001
Alfonso, Stephanie I; Callender, Julia A; Hooli, Basavaraj et al. (2016) Gain-of-function mutations in protein kinase Cα (PKCα) may promote synaptic defects in Alzheimer's disease. Sci Signal 9:ra47
Tinajero-Trejo, Mariana; Rana, Namrata; Nagel, Christoph et al. (2016) Antimicrobial Activity of the Manganese Photoactivated Carbon Monoxide-Releasing Molecule [Mn(CO)3(tpa-κ(3)N)](+) Against a Pathogenic Escherichia coli that Causes Urinary Infections. Antioxid Redox Signal 24:765-80
Robinson, J E; Paluch, J; Dickman, D K et al. (2016) ADAR-mediated RNA editing suppresses sleep by acting as a brake on glutamatergic synaptic plasticity. Nat Commun 7:10512
Majeski, Hannah E; Yang, Jing (2016) The 2016 John J. Abel Award Lecture: Targeting the Mechanical Microenvironment in Cancer. Mol Pharmacol 90:744-754
Yu, Olivia M; Miyamoto, Shigeki; Brown, Joan Heller (2016) Myocardin-Related Transcription Factor A and Yes-Associated Protein Exert Dual Control in G Protein-Coupled Receptor- and RhoA-Mediated Transcriptional Regulation and Cell Proliferation. Mol Cell Biol 36:39-49
Koechlein, Claire S; Harris, Jeffrey R; Lee, Timothy K et al. (2016) High-resolution imaging and computational analysis of haematopoietic cell dynamics in vivo. Nat Commun 7:12169
Meng, Fansen; Zhou, Ruyuan; Wu, Shiying et al. (2016) Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation. Genes Dev 30:1086-100

Showing the most recent 10 out of 159 publications